CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- 4 Open-market sale President and CEO sold 60,000 shares at an average $100.67 ($6,039,968)
- 4 Grant or award Chief Development Officer acquired 18,013 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 18,013 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 14,411 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 18,013 shares (grant or award)
- 4 Open-market sale General Counsel and Secretary sold 35,000 shares at an average $114.76 ($4,016,639)
- 4 Open-market sale President and CEO sold 69,407 shares at an average $116.33 ($8,073,772)
- 4 Open-market sale Chief Development Officer sold 9,484 shares at an average $114.95 ($1,090,140)
- 4 Open-market sale General Counsel and Secretary sold 9,483 shares at an average $114.94 ($1,090,021)
- 4 Open-market sale Chief Scientific Officer sold 9,482 shares at an average $114.95 ($1,089,911)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 21 · 403 filings